|
SELB
|
Selecta Biosciences, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RLYB
|
Rallybio Corporaton
|
0.02%
|
US
|
NASDAQ
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RANI
|
Rani Therapeutics Holdings, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
0.02%
|
US
|
NASDAQ
|
|
OPTN
|
OptiNose, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
OMIC
|
Singular Genomics Systems, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
OMGA
|
Omega Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
MRNS
|
Marinus Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
KRON
|
Kronos Bio, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
KMPH
|
KemPharm, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
KMDA
|
Kamada
|
0.02%
|
IL
|
TA
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
IMPL
|
Impel NeuroPharma, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
ICVX
|
Icosavax, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
0.02%
|
US
|
NASDAQ
|
|
FULC
|
Fulcrum Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|